Rep. Carter Calls for Report on PBMs' Impact on Rising Drug Costs
May 26, 2022
May 26, 2022
WASHINGTON, May 26 -- Rep. Buddy Carter, R-Georgia, issued the following news release and letter on May 25, 2022:
In a letter to Federal Trade Commission (FTC) Chair Lina M. Khan, Rep. Earl L. "Buddy" Carter (R-GA) called for an investigation into Pharmacy Benefit Manager's (PBMs) predatory practices, which lead to higher prices on prescription medications for patients.
Rep. Carter, a pharmacist by trade, is joined by fellow pharmacist Rep. Diana Harshbar . . .
In a letter to Federal Trade Commission (FTC) Chair Lina M. Khan, Rep. Earl L. "Buddy" Carter (R-GA) called for an investigation into Pharmacy Benefit Manager's (PBMs) predatory practices, which lead to higher prices on prescription medications for patients.
Rep. Carter, a pharmacist by trade, is joined by fellow pharmacist Rep. Diana Harshbar . . .